 |
| Global Embolization Market Size |
The global Embolization Market is estimated to be valued at US$ 1810.94 Mn in 2023 and is expected
to exhibit a CAGR of 8.1% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Overview:
Embolization procedures are minimally invasive treatments performed to reduce
or block blood flow to an area of the body. During the procedure, surgeons
thread a catheter through an artery to deliver embolic agents like gel foam
particles or liquid polymers that plug the blood vessel and stop blood flow.
This prevents blood from feeding tumors or aneurysms.
Market key trends:
One of the key trends in the embolization market is growing preference for
embolic agents over traditional surgical procedures. Embolization is less invasive
than open surgery and allows for reduced procedure time, less risk of
infection, and a quicker recovery. Moreover, advanced embolic agents can be
accurately placed using minimally invasive catheter procedures and image
guidance systems. This has increased the uptake of embolization procedures for
treating tumors, vascular malformations, and aneurysms.
Segment Analysis
The global embolization market is segmented based on product, procedure,
application, end-user, and region. Based on product, the embolization market is
segmented into embolic agents, embolization devices, and accessories. The
embolic agents segment dominated the global market in 2020 as it is widely used
during various interventional radiology procedures. Access to advanced embolic agents
and increasing adoption of minimally invasive procedures are fueling the growth
of this segment.
Key Takeaways
The Global
Embolization Market Size is expected to witness high growth, exhibiting
CAGR of 8.1% over the forecast
period, due to increasing preference for minimally invasive procedures over
traditional surgeries.
Regional analysis
North America dominated the global market in 2020 with a share of over 40%,
followed by Europe and Asia Pacific. Rising geriatric population, growing
prevalence of diseases requiring embolization, and high adoption of advanced
technologies drive the growth of these regional markets. The Asia Pacific
region is expected to witness the fastest growth owing to growing healthcare
infrastructure and medical tourism in the region.
Key players
Key players operating in the embolization market are IMBiotechnologies Ltd.,
ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation,
Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical
Systems, Inc., Cook Group, and Johnson & Johnson. Boston Scientific
Corporation holds the leading market position due to its wide product portfolio
for embolization.
Get
More Insights On This Topic: https://www.pressreleasebulletin.com/global-embolization-market/